These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 6421089)

  • 1. [Kinetics and mechanism of ftorafur decomposition. 1. Determination of expiration dates of ftorafur injection solutions].
    Hermann T; Grześkowiak E; Stypiński Z
    Acta Pol Pharm; 1983; 40(3):349-56. PubMed ID: 6421089
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effect of 5-fluorouracil, ftorafur, and imidazole carboxamide on the kinetics of the primary immune response in mice].
    Matveev AB; Kudriashov VM
    Farmakol Toksikol; 1981; 44(2):204-7. PubMed ID: 6791961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pharmcokinetics and toxic reactions of ftorafur in experimental and clinical intracarotid administration].
    Khagi KhB; Apinis TA; Gilev AP
    Farmatsiia; 1979; 28(2):59-60. PubMed ID: 220097
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparison of the actions of 5-fluorouracil and ftorafur in Escherichia coli.
    Saunders PP; Chao LY
    Antimicrob Agents Chemother; 1977 Mar; 11(3):451-4. PubMed ID: 324392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Ftorafur concentration in the blood and urine of oncological patients].
    Blokhina NG; Smolianskaia AZ; Aledseev VM; Sokolova VD
    Vopr Onkol; 1977; 23(8):33-7. PubMed ID: 333748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The pharmacology of ftorafur (R, S-1-(tetrahydro-2-furanyl)-5-fluorouracil.
    Au JL; Sadée W
    Recent Results Cancer Res; 1981; 76():100-14. PubMed ID: 6785848
    [No Abstract]   [Full Text] [Related]  

  • 7. Clastogenicity and sister chromatid exchange induction by ftorafur.
    Vrba M; Adámek R; Blasko M; Brezina V; Chrz R; Goetz P; Michalová K; Musilová J; Novotná B; Pogosianz HE; Raposa T; Siracký J; Sokova OI; Thust R; Ujházy V; Volgareva GM
    Neoplasma; 1981; 28(4):397-402. PubMed ID: 6793879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved liquid chromatographic assay for serum fluorouracil concentrations in the presence of ftorafur.
    Hornbeck CL; Floyd RA; Griffiths JC; Byfield JE
    J Pharm Sci; 1981 Oct; 70(10):1163-6. PubMed ID: 6795338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of millimeter band radio waves combined with ftorafur on the blood-forming system].
    Sevast'ianova LA; Potapov SL; Vasil'eva NN; Krusanova NI; Kubatkina EI
    Nauchnye Doki Vyss Shkoly Biol Nauki; 1976; (12):27-31. PubMed ID: 798607
    [No Abstract]   [Full Text] [Related]  

  • 10. [Effect of ftorafur on the chromosomes of human normal and tumor cells in vitro].
    Volgareva GM; Sokova OI; Pogosiants EE
    Genetika; 1979; 15(1):157-61. PubMed ID: 391642
    [No Abstract]   [Full Text] [Related]  

  • 11. [Gene mutation induction by the antitumor preparation ftorafur].
    Volgareva GM; Stavrovskaia AA; Pogosiants EE
    Genetika; 1982 May; 18(5):758-63. PubMed ID: 6807754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of tRNA 5-methyluridine methyltransferase and pseudouridine synthetase activities in 5-fluorouracil and 1-(tetrahydro-2-furanyl)-5-fluorouracil (ftorafur)-treated Escherichia coli.
    Frendewey DA; Kladianos DM; Moore VG; Kaiser II
    Biochim Biophys Acta; 1982 Apr; 697(1):31-40. PubMed ID: 6805514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GLC determination for ftorafur in biological fluids.
    Hills EB; Godefroi VC; O'Leary IA; Burke M; Andrzejewski D; Brukwinski W; Horwitz JP
    J Pharm Sci; 1977 Oct; 66(10):1497-9. PubMed ID: 336868
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolism and disposition of Baker's antifolate (NSC-139105), ftorafur (NSC-148958), and dichloroallyl lawsone (NSC-126771) in man.
    Loo TL; Benjamin RS; Lu K; Benvenuto JA; Hall SW; McKelvey EM
    Drug Metab Rev; 1978; 8(1):137-50. PubMed ID: 363378
    [No Abstract]   [Full Text] [Related]  

  • 15. 5-Fluorouracil concentrations in human plasma following R,S-1-(tetrahydro-2-furanyl)-5-fluorouracil (ftorafur) administration.
    Au JL; Sadée W
    Cancer Res; 1979 Oct; 39(10):4289-90. PubMed ID: 383283
    [No Abstract]   [Full Text] [Related]  

  • 16. Clastogenic effects of ftorafur. II. Cytogenetic analyses of bone marrow in mice.
    Goetz P; Novotná B
    Mutat Res; 1981 Mar; 88(3):301-6. PubMed ID: 6789196
    [No Abstract]   [Full Text] [Related]  

  • 17. [Biotransformation of ftorafur].
    Kozhukhov AN
    Vopr Med Khim; 1981; 27(2):243-7. PubMed ID: 6792775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human urinary metabolites of 1-(tetrahydro-2-furanyl)-5-fluorouracil (ftoraful).
    Benvenuto JA; Liehr JG; Winkler T; Farquhar D; Caprioli RM; Loo TL
    Cancer Res; 1979 Aug; 39(8):3199-201. PubMed ID: 378368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ftorafur: a self-limiting source of 5-fluorouracil?
    van Putten LM; Lelieveld P; Pantarotto C; Salmona M; Spreafico F
    Cancer Chemother Pharmacol; 1979; 3(1):61-6. PubMed ID: 119584
    [No Abstract]   [Full Text] [Related]  

  • 20. [Studies in vivo and in vitro on the influence of 5-fluorouracil and n'-(2'-furanidyl)-5-fluorouracil on the walker carcinosarcoma 256 in the rat (author's transl)].
    Mattern J; Volm M; Wayss K; Weber N
    Arzneimittelforschung; 1980; 30(6):981-4. PubMed ID: 6774738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.